Singapore, May 29 -- CPHI & PMEC China(June 24-26th) returns to the Shanghai New International Expo Center amid a marked surge in international interest, with industry momentum rebounding following a string of positive developments in global trade and pharmaceutical investment.

The 2025 edition is set to become the largest pharma event ever held in Asia, with more than 90,000 attendees and over 12,000 international executives expected.

The recent trade tariff reprieve, alongside an improving global outlook for pharma - i.e. higher valuations and improved capital expenditure by biotech and big pharma - is transforming into greater international interest at CPHI & PMEC China. International executives will visit the event in record numbers...